Provided by Tiger Fintech (Singapore) Pte. Ltd.

Astria Therapeutics Inc

5.57
+0.13002.39%
Post-market: 5.570.00000.00%19:30 EDT
Volume:1.35M
Turnover:7.54M
Market Cap:314.34M
PE:-2.97
High:5.64
Open:5.44
Low:5.41
Close:5.44
Loading ...
Feb 08, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2022

Major Issues Report

8-K - Current report
Jan 07, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 23, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 08, 2021

Major Issues Report

8-K - Current report
Aug 20, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 25, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 17, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 15, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 10, 2021

Major Issues Report

8-K/A [Amend] - Current report